September 23, 2021 | Deborah Kotz
University of Maryland Medicine
Tuesday, December 19, 2023
UM School of Medicine Review Highlights Rise in Psychiatric Disorders Linked to Increased Cannabis Use
The widespread use of cannabis (marijuana) and its increased potency are associated with a rise in cannabis-related psychiatric conditions, according to a new University of Maryland School of Medicine (UMSOM) review article that was recently published in the New England Journal of Medicine. It highlights the urgent need for doctors to screen for and treat patients who are experiencing symptoms of cannabis use disorder, which means they are experiencing significant problems from their use of the drug.
Friday, December 08, 2023
UM School of Medicine Celebrates the Life and Legacy of Former Psychiatry Chair, John A. Talbott, MD
It is with deep sorrow that we announce the news of the passing of internationally renowned psychiatrist John A. Talbott, MD, former Chair of Psychiatry and Professor Emeritus at the University of Maryland School of Medicine (UMSOM).
Friday, January 06, 2023
Neuroscience researchers now have access to 50 million brain cells to better understand how the brain develops and functions or changes with disease or trauma. Last month, scientists at the University of Maryland School of Medicine’s (UMSOM) Institute for Genome Sciences (IGS) unveiled a “one-stop shop” for brain cell data called the Neuroscience Multi-Omic Archive (NeMO Archive). This archive is now available to neuroscience researchers to transform their understanding of the complex workings of the brain.
Tuesday, August 30, 2022
University of Maryland School of Medicine researchers demonstrated that a stress response in the brain is essential for ketamine’s antidepressant response in mice suggesting new ways to improve antidepressant therapy for patients who do not respond to the treatment.
Thursday, May 14, 2020
Researchers Launch Study to Improve Prescribing of Clozapine for More Effective Management of Schizophrenia
Researchers at the University of Maryland School of Medicine and the Maryland Psychiatric Research Center are preparing to launch a new study to increase prescribing rates of the medication clozapine to treat schizophrenia. It will employ an innovative educational telementoring program called Project ECHO (Extension for Community Health Outcomes) that connects centralized experts to prescribers and clinicians throughout the state of Maryland.
Tuesday, October 31, 2017
Deanna Kelly, PharmD, BCPP, Professor of Psychiatry at the University of Maryland School of Medicine (UM SOM), has been awarded the 2017 Maltz Prize for Innovative and Promising Schizophrenia Research from the Brain and Behavior Research Foundation. The Maltz award is considered one of the top awards in the field of psychiatric disorders.
Wednesday, June 07, 2017
Dr. Jill RachBeisel Named Vice Chair for Clinical Affairs in UM School of Medicine’s Department of Psychiatry
Bankole A. Johnson, DSc, MD, MBChB, The Dr. Irving J. Taylor Professor and Chair for the Department of Psychiatry, Professor of Pharmacology, Anatomy and Neurobiology, along with UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that Jill RachBeisel, MD, Associate Professor of Psychiatry, has been named Vice Chair for Clinical Affairs for the UM SOM Department of Psychiatry, commencing at the start of the next academic year.